UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass

Anesthesiology (Philadelphia), 2005-02, Vol.102 (2), p.276-284

2005

Volltextzugriff (PDF)

Duloxetine for the Management of Diabetic Peripheral Neuropathic Pain: Evidence-Based Findings from Post Hoc Analysis of Three Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Studies

Clinical therapeutics, 2007, Vol.29 (11), p.2536-2546

2007

Volltextzugriff (PDF)

Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials

Human psychopharmacology, 2005-07, Vol.20 (5), p.327-341

2005

Volltextzugriff (PDF)

Long-Term Safety, Tolerability, and Efficacy of Duloxetine in the Treatment of Fibromyalgia

Seminars in arthritis and rheumatism, 2010-06, Vol.39 (6), p.454-464

2010

Volltextzugriff (PDF)

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

Pain (Amsterdam), 2008-06, Vol.136 (3), p.432-444

2008

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder

The journal of clinical psychiatry, 2011-04, Vol.72 (4), p.441-447

2011

Volltextzugriff (PDF)

Estimation of minimum clinically important difference for pain in fibromyalgia

Arthritis care & research (2010), 2011-06, Vol.63 (6), p.821-826

2011

Volltextzugriff (PDF)

A 1-year, open-label study assessing the safety and tolerability of vilazodone in patients with major depressive disorder

Journal of clinical psychopharmacology, 2011-10, Vol.31 (5), p.643-646

2011

Volltextzugriff (PDF)

Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder

Psychopharmacologia, 2006-10, Vol.188 (3), p.273-280

2006

Volltextzugriff (PDF)

Treatment benefits of duloxetine in major depressive disorder as assessed by number needed to treat

International clinical psychopharmacology, 2006-09, Vol.21 (5), p.267-273

2006

Volltextzugriff (PDF)

An evaluation of the cardiovascular safety profile of duloxetine : Findings from 42 placebo-controlled studies

Drug safety, 2007-01, Vol.30 (5), p.437-455

2007

Volltextzugriff (PDF)

A 1-year Safety and Efficacy Study of Duloxetine in Patients With Fibromyalgia

The Clinical journal of pain, 2009-06, Vol.25 (5), p.365-375

2009

Volltextzugriff (PDF)

Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder

Journal of affective disorders, 2005-12, Vol.89 (1), p.207-212

2005

Volltextzugriff (PDF)

The efficacy profile of vilazodone, a novel antidepressant for the treatment of major depressive disorder

Current medical research and opinion, 2012-01, Vol.28 (1), p.27-39

2012

Volltextzugriff (PDF)

A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder

Journal of psychiatric research, 2008-01, Vol.42 (1), p.22-34

2008

Volltextzugriff (PDF)

Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials

Journal of women's health (Larchmont, N.Y. 2002), 2007-10, Vol.16 (8), p.1145-1156

2007

Volltextzugriff (PDF)

Safety and tolerability of duloxetine treatment of diabetic peripheral neuropathic pain between patients with and without cardiovascular conditions

Journal of diabetes and its complications, 2009-09, Vol.23 (5), p.349-359

2009

Volltextzugriff (PDF)

Erratum to: Duloxetine for Neuropathic Pain Based on Recent Clinical Trials

Current pain and headache reports, 2011-10, Vol.15 (5), p.333-333

2011

Volltextzugriff (PDF)

The relationship between antidepressant and analgesic responses: findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorder

Current medical research and opinion, 2008-11, Vol.24 (11), p.3105-3115

2008

Volltextzugriff (PDF)

Time to response for duloxetine 60 mg once daily versus placebo in elderly patients with major depressive disorder

International psychogeriatrics, 2008-04, Vol.20 (2), p.309-327

2008

Volltextzugriff (PDF)

Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials

Clinical rheumatology, 2009-09, Vol.28 (9), p.1035-1044

2009

Volltextzugriff (PDF)

Comparisons of the Efficacy and Safety of Duloxetine for the Treatment of Fibromyalgia in Patients With Versus Without Major Depressive Disorder

The Clinical journal of pain, 2009-07, Vol.25 (6), p.461-468

2009

Volltextzugriff (PDF)

Duloxetine for the Management of Diabetic Peripheral Neuropathic Pain: Evaluation of Functional Outcomes

Pain medicine (Malden, Mass.), 2007-07, Vol.8 (5), p.410-418

2007

Volltextzugriff (PDF)

Is treatment-associated hypomania rare with duloxetine: Secondary analysis of controlled trials in non-bipolar depression

Journal of affective disorders, 2005-07, Vol.87 (1), p.115-119

2005

Volltextzugriff (PDF)

A Current Assessment of Rurally Linked Exposures as Potential Risk Factors for Sarcoidosis

Annals of epidemiology, 2001-02, Vol.11 (2), p.111-117

2001

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(32)
Science & Technology
(32)
Humans
(31)
Female
(26)
Male
(26)
Middle Aged
(23)
Adult
(22)
Biological And Medical Sciences
(21)
Duloxetine Hydrochloride
(21)
Medical Sciences
(21)
Double-Blind Method
(18)
Treatment Outcome
(16)
Thiophenes - Therapeutic Use
(15)
Depressive Disorder, Major - Drug Therapy
(13)
Duloxetine
(13)
Pharmacology. Drug Treatments
(13)
Psychology. Psychoanalysis. Psychiatry
(13)
Antidepressive Agents - Therapeutic Use
(12)
Psychiatry
(12)
Psychopathology. Psychiatry
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass

Duloxetine for the Management of Diabetic Peripheral Neuropathic Pain: Evidence-Based Findings from Post Hoc Analysis of Three Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Studies

Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials

Long-Term Safety, Tolerability, and Efficacy of Duloxetine in the Treatment of Fibromyalgia

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

A randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder

Estimation of minimum clinically important difference for pain in fibromyalgia

A 1-year, open-label study assessing the safety and tolerability of vilazodone in patients with major depressive disorder

Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder

Treatment benefits of duloxetine in major depressive disorder as assessed by number needed to treat

An evaluation of the cardiovascular safety profile of duloxetine : Findings from 42 placebo-controlled studies

A 1-year Safety and Efficacy Study of Duloxetine in Patients With Fibromyalgia

Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder

The efficacy profile of vilazodone, a novel antidepressant for the treatment of major depressive disorder

A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder

Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials

Safety and tolerability of duloxetine treatment of diabetic peripheral neuropathic pain between patients with and without cardiovascular conditions

Erratum to: Duloxetine for Neuropathic Pain Based on Recent Clinical Trials

The relationship between antidepressant and analgesic responses: findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorder

Time to response for duloxetine 60 mg once daily versus placebo in elderly patients with major depressive disorder

Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials

Comparisons of the Efficacy and Safety of Duloxetine for the Treatment of Fibromyalgia in Patients With Versus Without Major Depressive Disorder

Duloxetine for the Management of Diabetic Peripheral Neuropathic Pain: Evaluation of Functional Outcomes

Is treatment-associated hypomania rare with duloxetine: Secondary analysis of controlled trials in non-bipolar depression

A Current Assessment of Rurally Linked Exposures as Potential Risk Factors for Sarcoidosis

Suchergebnisse filtern